3,000
Participants
Start Date
September 30, 2025
Primary Completion Date
March 31, 2026
Study Completion Date
June 30, 2026
Guideline education and implementation intervention
"The intervention is implemented at the investigator level and the patient level, consisted of 3 parts:~1. Disease education~ * Investigator level:All investigators will receive COPD and CVD disease education according to Chinese Guideline pproximately 4 weeks before the first subject is enrolled.~ * Patient level:After the subjects are enrolled, the cardiologists and pulmonologist will provide disease education on their respective disease areas,education will be provided every 4 weeks until the end of the study.~2. Treatment:Cardiologists and pulmonologists will work together to provide treatment management for subjects with CVD and COPD.~3. Follow-up management:the subjects will be followed up every 4 weeks."
Research Site, Beijing
Research Site, Beijing
Research Site, Shanghai
Lead Sponsor
AstraZeneca
INDUSTRY